Clinical Trials Directory

Trials / Completed

CompletedNCT05971797

Rational-emotional Behavioral Therapy (REBT) in Patients With Osteoarthritis and Concomitant Diseases Before Arthroplasty

Rational-emotional Behavioral Therapy in Patients With Osteoarthritis and Concomitant Diseases Before Knee or Hip Arthroplasty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
95 (actual)
Sponsor
Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study was evaluation of the effectiveness of REBT on the emotional state of orthopedic patients with comorbidities before and after arthroplasty.

Detailed description

The studies assessed depression or anxiety in orthopedic patients by using Spielberger State-Trait Anxiety Inventory (STAI) and Hospital Anxiety and Depression Scale (HADS) before and after athroplasty. The comorbid background studied. The orthopedic patients with comorbidities were divided into several groups: arterial hypertension, chronic pyelonephritis , varicose veins, cardiovascular disease and atherosclerosis, diabetes mellitus, infection diseases, gastrointestinal diseases, obesity, neurological disorder, cerebrovascular accident, iron deficiency anemia, chronic bronchitis, hyperthyroidism, cardiac arrhythmia, other diseases. Patients with high levels of anxiety and depression underwent Rational Emotive Behavior Therapy before surgery. Patients without comorbidities and patients with comorbidities but without exposure considered as a control.

Conditions

Interventions

TypeNameDescription
BEHAVIORALREBTDuring REBT in patients with osteoarthritis and concomitant diseases with diagnosed depression or anxiety before arthroplasty the patients learn how to manage their irrational or unhealthy emotions, thoughts, and behaviors.

Timeline

Start date
2020-01-01
Primary completion
2021-01-01
Completion
2021-12-31
First posted
2023-08-02
Last updated
2023-08-03

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05971797. Inclusion in this directory is not an endorsement.